Answers are grounded in this paper and cite their sources.
Background: Obsessive–compulsive disorder (OCD) is a complex psychiatric disorder with a lifetime prevalence of about 3%. Because glutamate is thought to play a role in OCD, we investigated its relationship with DLGAP1 and GRID2, genes encoding a scaffold protein involved in glutamatergic signaling and a glutamate receptor predominantly expressed in the cerebellum, respectively. The present study aims to investigate the association of polymorphisms in the GRID2 (rs1030757) and DLGAP1 (rs9952159 and rs11081062) genes with OCD and its phenotypical characteristics. Methods: Case–control study including 200 OCD individuals and 203 healthy controls from the Brazilian population. The samples were genotyped using pre-designed TaqMan® assays through real-time polymerase chain reaction. Results: No association was observed between the studied polymorphisms and OCD status. However, in a dominant model for the rs1030757 C allele in men with OCD, positive and statistically significant associations were observed with dimensions of hoarding (p = 0.015, odds ratio (OR) = 3.059, 95% confidence interval (CI = 1.217–7.685) and neutralization (p = 0.044, OR = 2.429, 95% CI = 1.014–5.815). An effect against checking symptoms in women was observed in both the dominant (p = 0.029, OR = 0.252, 95% CI 0.068–0.932) and overdominant (p = 0.006, OR = 0.239, 95% CI 0.082–0.697) models. Conclusions: Our findings reveal preliminary, nominal associations between GRID2 variation and specific symptom dimensions of OCD. Given the exploratory, hypothesis-generating nature of this initial mapping, future confirmatory studies with larger independent sample sizes are essential to validate these trends under strict multiple-testing corrections.
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: